Implanet Past Earnings Performance

Past criteria checks 0/6

Implanet's earnings have been declining at an average annual rate of -9.4%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 5.5% per year.

Key information

-9.4%

Earnings growth rate

69.0%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate5.5%
Return on equity-197.2%
Net Margin-94.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Implanet makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:IM11 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 247-781
31 Mar 247-781
31 Dec 237-781
30 Sep 238-571
30 Jun 238-471
31 Mar 238-471
31 Dec 228-471
30 Sep 228-471
30 Jun 228-581
31 Mar 227-571
31 Dec 216-561
30 Sep 217-370
30 Jun 214-351
31 Mar 214-351
31 Dec 204-451
30 Sep 206-461
30 Jun 206-461
31 Mar 207-460
31 Dec 197-470
30 Sep 197-470
30 Jun 197-570
31 Mar 197-571
31 Dec 187-671
30 Sep 187-681
30 Jun 187-681
31 Mar 188-681
31 Dec 178-781
30 Sep 178-781
30 Jun 178-791
31 Mar 178-791
31 Dec 168-791
30 Sep 168-791
30 Jun 167-891
31 Mar 167-881
31 Dec 157-881
30 Sep 156-881
30 Jun 156-881
31 Mar 157-781
31 Dec 147-781
30 Sep 147-771
30 Jun 147-871
31 Mar 147-761
31 Dec 137-761

Quality Earnings: IM11 is currently unprofitable.

Growing Profit Margin: IM11 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IM11 is unprofitable, and losses have increased over the past 5 years at a rate of 9.4% per year.

Accelerating Growth: Unable to compare IM11's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IM11 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: IM11 has a negative Return on Equity (-197.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 06:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Implanet S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christophe Dombu YoutaAurgalys SAS
Jean-Pierre LozaIn Extenso Financement & Marché
Sébastien MalafosseODDO BHF Corporate & Markets